BEIJING, June 29 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced members of its Executive Management will ring the NASDAQ Stock Market closing bell on Tuesday, July 6, 2010.
Mr. Ping Chen, Dehaier's Chairman and CEO, said, "I am honored to ring NASDAQ's Closing Bell along with our management team on behalf of Dehaier Medical Systems. The ceremony is a symbol of yet another step towards our vision to be the largest and most reliable respiratory and oxygen homecare medical products and service provider in China."
Dehaier's management team will be available for one-on-one meetings with analysts and investors in New York City from July 7, 2010 to July 9, 2010. Interested parties and investors who wish to meet with the company's management team may contact Hawk Associates at 305.451.888, e-mail: email@example.com.
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third party components. The company also distributes products designed and manufactured by other companies including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents and proprietary technology. More information may be found at http://www.chinadhr.com .
Information for investors, including an investment profile about Dehaier is available at http://www.hawkassociates.com/profile/dhrm.cfm . An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors is available at http://www.hawkassociates.com .
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact: Investor contact: Hawk Associates Julie Marshall or Frank Hawkins Tel: +1-305-451-1888 Email: firstname.lastname@example.org
SOURCE Dehaier Medical Systems Ltd.